Global Drug Eluting Device Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Oncology, Ophthalmology and Other Applications), Product Type, Coating Type, Region, B

Global Drug Eluting Device Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Oncology, Ophthalmology and Other Applications), Product Type, Coating Type, Region, By Country: 2020-2030

Background

A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Drug Eluting Device Market (2024 Edition)”. According to the report, Global Drug Eluting Device Market was valued at USD 6586.26 Million and is expected to grow at a CAGR of 6% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Oncology, Ophthalmology and Other Applications), By Product Type (Coronary Drug Eluting Stents, Peripheral Drug Eluting Stents, Drug Eluting Balloons and Drug Eluting Implants) and By Coating Type (Polymer Based and Non-Polymer Based)

Market Overview

The Drug Eluting Device Market is growing rapidly, fueled by the increasing prevalence of chronic diseases, such as cardiovascular diseases, cancer, and diabetes, which require long-term treatment and drug delivery solutions. Drug eluting devices are medical devices that release a therapeutic drug over time, directly at the targeted site, offering a more localized and controlled treatment compared to systemic drug administration. These devices are particularly useful in treating conditions where sustained drug release is necessary, such as in stent implantation for cardiovascular diseases.

One of the primary drivers of the market is the rising incidence of cardiovascular diseases, which has led to an increased demand for drug eluting stents. These stents are used to treat narrowed or blocked arteries by releasing anti-proliferative drugs, reducing the risk of restenosis (re-narrowing of the artery). The growing aging population, coupled with lifestyle-related risk factors such as obesity, smoking, and physical inactivity, has contributed to the rising number of cardiovascular interventions, thus boosting the demand for drug eluting devices.

Moreover, advancements in drug eluting technologies, such as the development of bioresorbable stents and polymer coatings, have improved the efficacy and safety profiles of these devices, further driving market growth. The oncology segment is also experiencing increased demand for drug eluting devices, as they provide targeted and localized drug delivery for cancer treatment, minimizing the side effects associated with chemotherapy. The ongoing innovation in material science and drug formulations is expected to open new avenues for the market in the coming years.

Segment Insights

The cardiovascular segment holds the largest share of the Drug Eluting Device Market, accounting for around 60% of the market in 2023. The increasing use of drug eluting stents in treating coronary artery diseases is a key driver of this segment. The oncology segment is also growing, driven by the need for localized drug delivery in cancer treatment.

Geographical Insights

The Americas lead the Drug Eluting Device Market, with the U.S. being a major contributor due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and strong focus on medical innovation. Europe and the Asia-Pacific region are also significant markets, with increasing healthcare expenditure and rising demand for advanced medical devices.

Market Segmentation

By Application:

• Cardiovascular Diseases
• Peripheral Vascular Diseases
• Oncology
• Ophthalmology
• Other Applications

By Product Type:

• Coronary Drug Eluting Stents
• Peripheral Drug Eluting Stents
• Drug Eluting Balloons
• Drug Eluting Implants

By Coating Type:

• Polymer Based
• Non-Polymer Based

By Geography

• Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
• Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
• Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Drug Eluting Device Market include:

• Terumo
• Becton, Dickinson and Company
• Orbus Neich
• Biotronik SE
• Philips Group
• Medtronic Plc
• Lepu Medical
• Abbott Laboratories
• Cordis Corp
• Boston Scientific Group
• Other Leading Companies

Reasons to buy this report:

• In-Depth Comparative Assessment of Top 20 Markets in the Drug Eluting Device Market Product Type: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
• Comprehensive Historical, Present, and Future Analytics of the Drug Eluting Device Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Drug Eluting Device Market.
• Detailed Analysis of Drug Eluting Device Market By Application, Product Type, and Coating Type Across 20 Countries
• Beyond the Purchase: 90 Days of Support
• Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
• Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
• Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
• Strategic Product Type Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.

*Please Note: The report will be delivered in 2 business days upon order confirmation*